Medy-Tox Inc. is a biopharmaceutical company.  The Company researches, develops and manufactures biopharmaceutical products using clostridium botulinum which is a microorganism toxin.

Decision on Acquisition of Treasury Stock

Report on Business Performance according to Consolidated Financial Statements (Fair Disclosure)

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Medy Tox Inc (086900 KS)

Decision on Acquisition of Treasury Stock

Report on Business Performance according to Consolidated Financial Statements (Fair Disclosure)

[Revised] Report on Business Performance according to Consolidated Financial Statements (Fair Disclosure)

Decision on Disposal of Treasury Stock

Decision on Cash Dividend and Dividend in Kind

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)